Human epidermal growth factor receptor 2 (HER2), which is frequently overexpressed in a wide range of human cancers, is one of the most commonly targeted antigens, not only by monoclonal antibodies, but also by T-BsAbs. The gene discussed is ERBB2; the disease is cancer.